research library
-
CBD: From an inactive cannabinoid to a drug with wide spectrum of action
-
CBD as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
CBD: An overview of some chemical and pharmacological aspects
-
The endocannabinoid system as an emerging target of pharmacotherapy
-
Targeting the endocannabinoid system with cannabinoid receptor agonists
-
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
-
Understanding the molecular aspects of THC and CBD as antioxidants
-
Letters to Nature: Leptin-regulated endocannabinoids are involved in maintaining food intake
-
The endocannabinoid system in targeting inflammatory neurodegenerative diseases
-
That which we call Indica, by any other name would smell as sweet
-
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
-
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
-
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
-
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
-
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
-
The therapeutic potential of the endocannabinoid system for Alzheimer’s disease
-
A molecular link between the active component of marijuana and Alzheimer’s disease pathology
-
Neuroprotective effect of CBD... on beta-amyloid-induced toxicity in PC12 cells
-
The Potential Therapeutic Effects of THC on Alzheimer’s Disease
-
The role of the endocannabinoid system in Alzheimer’s disease
-
The role of phytochemicals in the treatment and prevention of dementia
-
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
Biliary Tract Cancer
Blood Cancer
Brain Cancer
-
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas
-
Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines
-
A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
-
Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor
Breast Cancer
-
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
-
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
Colorectal Cancer
Liver Cancer
Lung Cancer
Mouth & Throat Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Uterine, Testicular, & Pancreatic Cancer
-
CBD reduces intestinal inflammation through the control of neuroimmune axis
-
Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice
-
Cannabinoids and the gut: New developments and emerging concepts
-
Cannabinoids and gastrointestinal motility: Animal and human studies
-
Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis
-
Endocannabinoid system dysfunction in mood and related disorders
-
The endocannabinoid system and the treatment of mood and anxiety disorders
-
Endocannabinoid signaling in the etiology and treatment of major depressive illness
-
Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors
-
Serum contents of endocannabinoids are correlated with blood pressure in depressed women
-
Report of a parent survey of CBD-enriched cannabis use in pediatric treatment-resistant epilepsy
-
Medicinal marijuana stops seizures, brings hope to a little girl
-
Cannabis, CBD, and epilepsy – From receptors to clinical response
-
Chronic administration of CBD to healthy volunteers and epileptic patients
-
Endocannabinoid system protects against cryptogenic seizures
-
From the Editors: Cannabidiol and medical marijuana for the treatment of epilepsy
-
CBD exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
-
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo
-
The endocannabinoid system: an emerging key player in inflammation
-
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice
-
Cannabinoids, endocannabinoids, and related analogs in inflammation
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
-
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
-
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
-
Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis
-
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
-
Sativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis
-
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
-
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
-
Sativex successfully treats neuropathic pain characterised by allodynia: clinical trial
-
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue
-
Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis
-
Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
-
CBD Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts
-
Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies
-
Cannabinoids and the skeleton: From marijuana to reversal of bone loss
-
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy
-
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
-
Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis
-
Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family
-
The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD
-
Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear
-
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors
-
Non-antidepressant long-term treatment in post-traumatic stress disorder
-
CBD exerts sebostatic and antiinflammatory effects on human sebocytes
-
The endocannabinoid system of the skin in health and disease
-
Epigenetic control of skin differentiation genes by phytocannabinoids
-
Attenuation of allergic contact dermatitis through the endocannabinoid system
-
Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus